From the end of 1994 to the beginning of 1995, 49 patients with hemorrhagic symptoms were hospitalized in the Makokou General Hospital in northeastern Gabon. Yellow fever (YF) virus was first diagnosed in serum by use of polymerase chain reaction followed by blotting, and a vaccination campaign was immediately instituted. The epidemic, known as the fall 1994 epidemic, ended 6 weeks later. However, some aspects of this epidemic were atypical of YF infection, so a retrospective check for other etiologic agents was undertaken. Ebola (EBO) virus was found to be present concomitantly with YF virus in the epidemic. Two other epidemics (spring and fall 1996) occurred in the same province. GP and L genes of EBO virus isolates from all three epidemics were partially sequenced, which showed a difference of õ0.1% in the base pairs. Sequencing also showed that all isolates were very similar to subtype Zaire EBO virus isolates from the Democratic Republic of the Congo.
Johnson et al. [1] isolated and identified Ebola (EBO) virus associated with a mortality rate similar to that seen during the DRC and Sudan epidemics [7] . from human cases during a 1976 epidemic of hemorrhagic fever (HF) in the Democratic Republic of the Congo (DRC).
During 1994 and 1995, an outbreak of HF occurred in northeastern Gabon. It was first considered to be caused only by During the same year, EBO virus was isolated from patients during an HF epidemic in Sudan [2] . The viruses, which were yellow fever (YF) virus on the basis of the clinical symptomatology, routine biochemical tests, and specific laboratory reclosely related to Marburg virus (all members of the Filoviridae), had an 88% and a 53% case fatality rate in DRC [3] and sults provided by the Centre National de Référence des Fièvres Hemorragiques Virales (Institut Pasteur, Paris) [8, 9] . However, Sudan [2], respectively. A third outbreak, with a case fatality of 60%, occurred in Sudan in 1979 [4] . In addition, a death retrospective serologic tests detected concomitant EBO virus antibodies among some of the patients and the general populawas registered in Tandala, DRC, in 1979 [5] . In 1994, a new strain of EBO virus was isolated from a Swiss researcher with tion [10, 11] . Later efforts to isolate the EBO virus from some of the specimens from the first epidemic (1994) were successa dengue-like syndrome, who had likely been infected during the necropsy of a chimpanzee (see Formenty et al., this suppleful. One year later, in February and in July 1996, two more HF outbreaks occurred in northeastern Gabon [10 -13] . ment). The animal had been found dead in the TaıF National Forest (Côte d'Ivoire) during a 2-year epidemic that killed half Herein, we report on three EBO epidemics that occurred between late 1994 and early 1997 in northeastern Gabon [10] . of the population of chimpanzees [6] . A third serious human epidemic of EBO occurred in 1995 in Kikwit, DRC; it was
The Epidemics
It is important to note that during this investigation, we Informed consent was obtained from the patients or their parents or guardcontinually faced many difficulties (e.g., logistics problems and ians.
Financial support: CIRMF is supported by the Republic of Gabon, the French cultural and political constraints) in the collection of data and the difficulties sometimes led to the loss of important informa-situated in small clearings of 2000 -3000 m 2 at the edge of the the physicians in charge of the Makokou hospital (a very poorly equipped facility), was rather broad, and at least 4 of the 49 rain forest. Figure 1 and table 1 show the geographic location of these and other villages with case-patients. Table 1 also patients appeared unlikely to have HF. On 18 December 1994, during the middle of the first wave, the Gabonese health authorshows the chronology of illness for the cases. Three hundred fifty people, mainly of the Bakota ethnic group but also some ities requested that we examine 9 patients in Makokou General Hospital. Biologic samples from those patients led to the identiBakwélé, inhabit this area (30 in Mékouka, 20 in Andock, and 300 in Minkébé).
fication of the etiologic agents. Between December 1994 and March 1995, CIRMF collected A total of 32 sick persons from the three forest encampments (23 from Mékouka, 4 from Andock, and 5 from Minkébé) 22 samples in Mayela from contacts (all §15 years old) of sick persons and 88 samples from the local population of traveled 100 km south by river to the nearest hospital at Makokou, the main town of the region, for treatment. In addition to
Ogooué-Ivindo Province, Gabon, where the epidemic occurred.
At that time, many people had fled the area in terror; therefore, the primary cases in Andock, we were also informed that deaths had occurred in the local population of great apes (chimpanit was difficult to conduct an investigation. A year later (January 1996), we sampled 236 people from the three initially infected zees, Pan p. troglodytes, and gorillas, Gorilla g. gorilla). However, despite intensive searches of the forest by teams from villages and from villages in the Makokou area in order to further assess exposure to EBO virus in the local population. Centre International de Recherches Médicales de Franceville (CIRMF), no cadavers or skeletons were ever found, even when Second epidemic (spring 1996) . A second epidemic began during early February 1996 in the village of Mayibout 2, Gaa patient told us that he had killed a chimpanzee with abnormal behavior inside his encampment. This report could be anecbon, which is located on the Ivindo River. Mayibout 2 is 40 km south (6 h by boat) of Mékouka and Andock, where the dotal, but it cannot be totally ignored.
The second wave of patients did not originate from the enfirst epidemic broke out, and north of Makokou (7 h by boat).
Eighteen people who had skinned and chopped a chimpanzee campments: They were what we should have called (in a survey following accepted procedures) secondary (or tertiary ?) cases.
cadaver that they found became ill (fever, headache, bloody diarrhea). They were evacuated from Mayibout 2 to Makokou Unfortunately, the information that was available from the authorities regarding these patients did not provide a precise geneon the decision of the village chief, despite governmental instructions to the contrary. All patients were admitted to Makoalogy of all cases. The first patient in the second wave was from Mayela, a small village close to Makokou, far from the kou Général Hospital, where 4 moribund patients died within 48 h. forest encampments. This person, who was probably the first secondary or tertiary case, lived near a traditional healer (a The bodies of the 4 patients were returned by river to Mayibout 2; a fifth patient, who was moribund when he escaped ''nganga'') and was probably infected as a result of contact with a hospitalized patient who, against medical advice, left from the hospital, died after returning to Mayibout 2. Traditional burial ceremonies were performed without any special the hospital to seek care from the nganga. Sixteen more cases (table 1) occurred in mid January: 1 case at Makokou Général precautions to avoid disease transmission. Two other ''primary cases'' occurred, which appeared not to be connected to the Hospital, 12 cases from Mayela, and 3 cases from two villages (Ekataniabé, 1 patient; Ekobakoba, 2 patients) on the road chimpanzee episode; 1 died. Fifteen serum samples from these initial 18 primary cases and 6 from secondary and tertiary cases running south toward Franceville. None of these patients had been in the area affected by the first wave of the epidemic were obtained. An additional 205 serum samples were obtained from the population of Mayibout 2 and neighboring villages during the previous 3 months; however, all had been either in direct contact with sick relatives (people hospitalized at Mako-(Mayibout 1 and Mvadi, which are 2 km south and 20 km north, respectively, of Mayibout 2). kou Général Hospital or sleeping in the nganga traditional healer's home) or with people caring for patients.
Third epidemic (fall 1996) . On 5 October 1996, we informed the Gabonese health authorities (who 1 week earlier The last reported case (infected while caring for a relative at Makokou's hospital) occurred at Ekobakoba on 9 February had requested our assistance in the investigation) that we had isolated EBO viruses from 2 of 6 samples from patients hospi-1995, and the epidemic was declared over by Gabonese health authorities on 17 February 1995. talized at Booué. Personnel from CIRMF carried out a retrospective investigation of this third epidemic, which probably Overall, 49 persons were admitted to Makokou's hospital with suspected HF. Patients were suspected of having HF if started as early as 13 July with the death (undeclared) of a 39-year-old hunter in a logging camp near Booué (0Њ06 S, 11Њ57 they had a well-identified contact with an ill person or at least two of the following clinical signs: fever, diarrhea, vomiting, E) between Ovan and Koumameyong, 200 km from Mékouka and 120 km from Makokou to the southwest ( figure 1 ). The melena, conjunctivitis, arthralgia or myalgia, diarrhea, or vomiting. Of the first 9 patients, 2 who we examined during the symptoms of this first case were suggestive of viral HF (VHF; fever, bleeding, vomiting, diarrhea, and headache). At the befirst wave also had jaundice, which has never been described as a symptom of EBO infection but is consistent with YF ginning of August 1996, information was obtained that several chimpanzees may have died in the same area, and a field collabinfection. This case definition of HF, which was proposed by 
orator was able to obtain skin samples from 1 cadaver for The epidemic was declared over in March 1997 (last officially declared patient: 18 January), with a total of 60 cases pathologic examination at the Centers for Disease Control and Prevention (CDC, Atlanta), with which CIRMF was in contact.
and 45 deaths. Unfortunately, the information made available to us from the local authorities did not allow for a very precise Six weeks later, at the end of August, a second hunter (35 years old) died in the same Gabonese logging camp, but his genealogy of all cases; however, we did obtain accurate data on 47 of the 60 cases (Milleliri JM, unpublished data). death, which was also suggestive of VHF, was not linked to that of the first hunter. A third hunter (26 years old) became ill 12 days later and was hospitalized at Booué. He subsequently Materials and Methods evaded the medical authorities at Booué and died in the village of Balimba, where he was being treated by a nganga. Shortly
Routine Clinical Chemistry Tests
after the hunter's death, both the nganga and his nephew fell Routine clinical chemistry tests were done on sera from some ill in mid-September and were admitted first to Booué Hospital hospitalized cases in each epidemic.
and then transferred to Makokou General Hospital, where they died. Three other cases, including another nganga, occurred among people living in the same area.
one well, we used as antigen a cell slurry made in EBO-infected known from previous experience to identify EBO antigen for different strains of virus in tissues. In the first assays we used 2 standard serum samples as positive tracted according to the method of Chomczynski and Sacchi [18] , and the presence of the YF viral genomic RNA was revealed by controls. As soon as we had confirmed the EBO cases, we added our own 2 positive controls, which were run in standard dilution reverse transcriptase-polymerase chain reaction (RT-PCR) amplification [19] using consensus primers for flaviviruses. The ampliseries for providing standard curves, which allowed the determination of the limits of detection of the assay. A panel of 4 negative fied DNA fragment was then transferred onto a nitrocellulose membrane and hybridized with a YF virus-specific probe. sera (from healthy persons) were run in all tests to determine the background of the assay (the limit at which the positive controls are positive) and to provide the mean and standard deviation (SD) Antigenemia of that background. A sample was considered to be positive if its optical density exceeded the mean / 3 SD of the controls. Plates
The sera of sick people, their contacts, and people suspected of were read spectrophotometrically at an optical density of 410 nm having EHF were tested by EIA for the presence of EBO antigen, on a microcomputer (LP 200; Sanofi Diagnostics Pasteur, Marnesas were the supernatants of Vero E6 cells seeded with sera from la-Coquette, France).
these persons. Half of a 96-well microtitration plate was coated IgG anti-EBO EIA. For IgG detection, half of a 96-well mi-(overnight at 4ЊC) with a mouse monoclonal antibody recognizing crotitration plate was coated with a lysate of EBO-Z-, EBO-S-, EBO virus epitopes; the other half was coated with normal myand EBO-R-infected Vero E6 cells, and the other half was coated eloma ascites diluted 1:1000 in PBS. Biologic samples to be with a lysate of uninfected Vero E6 cells to determine the specific checked for the presence of EBO antigen were then added (first binding of antibody to virus antigens (the background); both lyat a dilution of 1:4 and then 4-to 64-fold). After a 1-h incubation sates were diluted 1:1000 in PBS. Plates were incubated overnight at 37ЊC in a humid chamber, the plates were washed 3 times, and at 4ЊC. The plates were washed three times with PBS plus 0.1% rabbit anti-EBO (subtypes Z, S, and R) diluted 1:2000 in serdil (vol/vol) Tween 20, and then sera were added at a 1:100 and 4-was added and incubated for 1 h at 37ЊC in a humid chamber. to 800-fold dilutions in serdil and allowed to react with the antigenPlates were incubated for 1 h with anti-rabbit IgG conjugate (no. coated wells for 60 min at 37ЊC in a humid chamber. Bound IgG 074-1506; Kirkegaard & Perry) diluted 1:10,000 in serdil and then was detected with mouse anti-human IgG conjugated to horseradincubated for 30 min using an H 2 O 20 ABTS substrate (Kirkeish peroxidase. Further identification was done as in the IgM EIA gaard & Perry), and bound rabbit IgG was detected. assay. A panel of specific IgG-positive controls and specific IgGnegative sera (from healthy persons) was run in all tests in order to determine the cutoff value. For each assay, the mean and SD
Results
of the adjusted optical density were accumulated and used to calculate a value equal to the mean / 3 SD, which represented the Serologic surveys. The occurrence of HF cases in the fall cutoff value. Plates were read as above.
of 1994 initially led us to suspect an outbreak of sylvatic YF Anti-YF IgM EIA. At the beginning of the first VHF epidemic, infection. However, we were aware that another HF agent (in YF virus was strongly thought to be the probable cause of illness, particular EBO virus) could be circulating, given the possible on the basis of the clinical and epidemiologic results of the 9 fatalities observed in nonhuman primates (apes replicate YF patients examined. Therefore, we tested for YF virus infection, virus, but they usually do not die from it; Monath TP, personal using IgM capture techniques [17] . communication).
In the first instance, we screened 9 patients (all from Makokou General Hospital) for HF virus. EBO IFA on CRELM Virus Isolation Attempts slides was negative for all 9 serum samples, whereas 6 of 9 Vero E6 cell 6-well plates were inoculated with sera from pa- of IFA on CRELM slides. However, the antigen used in our We also used ELISA to test the 88 serum samples obtained years.
In the fall 1996 epidemic, there were 60 cases and 45 deaths in January 1995 (before YF vaccination) from the population living around the three encampments (Andock, Minkébé, and (case fatality rate, 75%). The sex ratio was 2.4. We were unable to conduct adequate surveys during the epidemic, so complete Mékouka) where the first epidemic broke out and the 22 serum samples obtained from contacts in Mayela. Two of these sera age-range data are unavailable. The development (geographically and chronologically) of the (1.8%) were positive for anti-EBO IgG but not EBO IgM, while 9 YF-unvaccinated people (8.1%) were positive by YF first two epidemics is shown in table 1 and figures 2 and 3, respectively. When tracing the computerized (MS Access software; IgM capture, indicating a recent YF virus circulation.
One year later, we obtained samples from 236 persons from Microsoft, Redmond, WA) polynomial regression curves obtained from histograms, the first epidemic shows two waves of morbidity, the same area (table 1) . For various reasons, only 56 of the original 110 people were part of this second cohort (e.g., use whereas in the second outbreak, there is only one peak of morbidity. These observations are related to the notably different types of given name in the place of family name in original survey, fear of being identified and accused of causing the original of spread in the two epidemics. Persons in several villages were infected during the first epidemic, which lasted longer than the epidemic, and migrations of populations). Of 236 subjects, 24 (9.7%) had anti-EBO IgG by ELISA without any anti-EBO second, in which only persons in a confined area were affected. The exact origin(s) of the virus in the first epidemic is uncertain, IgM (1 of these IgG-positive cases was the first case of the first wave in the 1994 epidemic and had survived a typical and despite reports of the death of great apes, we were unable to confirm these reports. EBO-type illness).
During the second epidemic, 205 samples were collected Exploitation of the area by gold miners has caused substantial disturbance to the forest canopy. This disturbance may from people living in 3 villages (Mayibout 1 and 2, where EBO was known to have occurred, and Mvadi, where 1 unconhave caused contact between other species and humans that otherwise would not have occurred. None of the specimens firmed death of a hunter was said to have occurred). High frequencies of anti-EBO IgG (14.9% -30%) and IgM (5.7% -(small mammals and insects) collected in the field so far have yielded any sign of harboring the virus; however, these studies 10.0%) by ELISA in all three villages (table 2) may suggest the presence of an asymptomatic or mild form of the disease are ongoing. In the second outbreak, there is no doubt that the virus came concomitant with the classical severe form of EBO, or they may demonstrate the limits, in terms of specificity, of the EBO from one source, a chimpanzee infected by EBO (for which the chain of infection is unknown). The chimpanzee seems to IgG and IgM ELISAs that we used.
During the initial phases of the third epidemic, we were have been the index case for infecting 18 primary human cases. There were 2 other primary cases, for whom we have no inforunable to carry out serologic surveys due to local reasons that were out of our control. mation on the source of infection (the role of a nganga was suspected), making a total of 20 primary cases for this epiFatality and descriptive epidemiology. We reviewed files at Makokou General Hospital for persons who were seen during demic. Only those people who had been in contact with the dead chimpanzee before it was cooked for eating were affected; the first epidemic in fall 1994; 49 patients were identified with at least two signs of VHF, 29 of whom died (case fatality rate, nobody was infected by eating the cooked meat. We identified 10 secondary cases involving close contacts of dead or dying 59%). There were 26 male and 23 female patients (sex ratio, 1.1) with a mean age of 37 years.
people and 1 tertiary case. It is important to note that no cases of infection occurred among the professional medical personnel because of preventive measures that were set in place on the second day of the epidemic. All equipment and material neces- were provided. One hundred ninety-one contacts were traced, with no evidence of infection by EBO virus. Immunostaining [15] done at the CDC on skin biopsies from tients in the cohort, 6 died. Data were obtained 4 -7 days after the onset of disease (16 days after the patients were infected a chimpanzee found dead in the forest indicated the presence of EBO [16] ; however, the ape is very unlikely to have had by a chimpanzee cadaver). The levels of direct and conjugated bilirubin were normal, but all patients had signs of liver any contact with humans.
Biologic and clinical features. Clinical signs and sympinvolvement (i.e., elevations in g-glutamyltransferase, aminotransferase, and alkaline phosphatase), and 23% had signs of toms observed in 15 serologically or virologically confirmed patients from the outbreak at Mayibout 2 (spring 1996) are slightly decreased renal dysfunction (elevated serum creatinine and urea). presented in table 3. Fever was always present, while in Ç75% of the cases, diarrhea (a dense suspension of black or brownMost of the other blood parameters (e.g., total serum proteins, albumin, uric acid, cholesterol, triglycerides, sodium, pored uneven microaggregates õ5 mm in size in liquid or syrupy stools) and vomiting were seen, and Ç50% had conjunctivitis tassium, and chloride) that we were able to test were normal. Characterization of virus strains. EBO viruses were isoor conjunctival bleeding. Taking only the second epidemic into consideration, since it was the best-documented outbreak, lated from patients from each of the three epidemics. All the Gabonese virus strains sequenced showed a high level of hoclinical signs and symptoms were observed between days 6 and 11 after handling the chimpanzee, and deaths occurred mology with the group of strains from DRC [16] . Viruses isolated from patients during the same outbreak had identical between days 12 and 18 after the appearance of signs or symptoms. Despite a small number of observations, it seemed to us base-pair sequences, but base-pair sequences were slightly different for isolates from the individual outbreaks. There was that those who died had a shorter incubation period than those who survived.
only a four-nucleotide (nt) difference in the GP gene in each of the 3 Gabonese strains (i.e., the GP gene from the December Table 4 presents the biologic and biochemical data for 13 patients infected during the spring 1996 outbreak. Of 13 pa-1994 strain differs from that of the February 1996 strain by / 9d49$$se13 01-12-99 11:06:39 jinfa UC: J Infect four nt, and the February strain differs from the October 1996 Discussion strain by 4 nt).
An epidemic of HF among humans, some of whom had A conserved region of the L gene was also amplified in virus clinical and biologic symptoms suggestive of YF infection, strains from fall 1994 and fall 1996, using degenerate primers started in December 1994 in Ogooué-Ivindo Province. On the selected from sequences of EBO-S and Marburg virus strains; basis of clinical, biologic, and serologic data, a diagnosis of PCR products were subsequently sequenced [13] . The 2 Gabo-YF infection was suspected in 6 hospitalized cases, and a diagnese strains showed high homology in the first 156-bp senosis of YF infection was confirmed for 3 other cases on the quence, with only a single base change (position 110; A to G) basis of molecular biology data, although the complete virus separating the 2 strains. As stated, during the first epidemic, 6 could not be isolated, which is not unusual for YF virus. (YF of 9 patients had anti-YF IgM. At the Institut Pasteur, using virus is known to be impossible or difficult to isolate from PCR and specific hybridization techniques, YF sequences were clinical material if samples are taken several days after evoluidentified in sera from 2 of the 6 patients who were anti-YF tion of the clinical disease; for example, during the 1970 epiIgM positive and in 1 of the 3 patients who had no antidemic in Okwooga and the 1986 epidemic in Oju region, Nige-YF IgM. Those 3 patients, who were negative for all EBO ria, it was impossible and difficult, respectively, to isolate YF investigations, had clinical signs compatible with YF (e.g., virus [Monath TP, personal communication] known that sylvatic YF infection can exist in a mild or symp- Asthenia 27 tom-free form [17] . Cephalgia 27 A final argument for the presence of YF virus during the Melena 27 first epidemic (fall 1994) comes from Pisano et al. [20] , who Hiccups 27 identified YF infection in a cohort of 5 patients (different from Asibi strain of YF virus [21] . Epistaxis 13 During the first epidemic, EBO and YF viruses were obvi- [25 -27] . However, these results to limit the spread of this disease. Nosocomial spread of infection due to the lack of recognition of the disease and the dearth of must be examined carefully since others have suggested that IFA is likely to give false-positive results [28] . In addition, in training and material available to establish simple barrier nursing remains the root cause of most of the disease observed to date. our hands, this test was insensitive for EBO virus, specifically during the fall 1994 epidemic, in which all sera collected during From the public health point of view, this remains a basic goal for the prevention of EHF epidemics. Preventing primary infection the acute phase of the disease tested negative by IFA, while some were positive by EIA. Even though ELISA techniques certainly requires the identification of risk factors and the reservoir, something that continues to elude us all. appear to be very sensitive for assessing EBO infection, we must be cautious about their specificity.
No serologic data were available from persons in Ogooué-
